Radiation Therapy for Non-Melanoma Skin Cancer

 

A machine is used to target high-energy rays specifically at the cancerous area. Radiation therapy (also called radiotherapy) is not a common treatment for skin cancer, but may be used in certain instances, such as when the cancer is in an area that makes surgery difficult or when the patient is not a good candidate for surgery because of age or health reasons. This treatment may also be used in very advanced cases or when skin cancer recurs after initial surgical treatment.

The way in which radiation therapy is delivered depends on the extent and type of non-melanoma skin cancer that is being treated:

  • External radiation therapy is delivered by a machine that aims radiation beams directly to the cancer site.
  • Internal radiation therapy is given by sealing radioactive medicine in a small device, such as a needle, “seed,” wire, or catheter (thin, hollow, flexible tubing), that is placed directly into or close to the site of the cancer.

Side effects from radiation therapy are common but usually temporary. They may include soreness, redness, or blistering at the radiation site, or hair thinning or loss.

This content has been reviewed and approved by Myo Thant, MD.

This content was last modified on February 21, 2008 .
Latest Cancer News
HPV infection rates similar in men and women

October 10, 2008 — NEW YORK (Reuters Health) - Although men are at high risk of acquiring human papillomavirus (HPV) infections, most last no more than a year, about the same time this sexually transmitted disease persists in women, researchers report in The Journal of Infectious Diseases.

Cancer common after liver transplantation

October 10, 2008 — NEW YORK (Reuters Health) - People who undergo liver transplantation, particularly children, are at increased risk for developing cancer, Finnish researchers report in the journal Liver Transplantation.

Lung cancer in non-smokers a separate disease

October 10, 2008 — NEW YORK (Reuters Health) - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.

Select news items provided by Reuters Health